Page 257 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 257

Cryoglobulinemic Vasculitis                                              231

Table 1. Cryoglobulinemic vasculitis: Demographic, Clinicoserological and Virological
                                  Findings at a Single Institution*

Total Number of Patients                               270
Mean age at disease-onset (± SD), years (range)        55 (±14) (29-74)
Female/Male ratio                                      3:1
Disease duration, mean ± SD years (range)              14 (±11) (2-42)
Purpura                                                98%
Weakness                                               98%
Arthralgia                                             93%
Non-erosive arthritis                                  9%
Raynauds phenomenon                                    32%
Sicca syndrome                                         51%
Peripheral neuropathy                                  81%
Renal involvement                                      32%
Liver involvement                                      73%
B-cell non-Hodgkin lymphoma                            12%
Hepatocellular carcinoma                               3%

     Mean cryocrit% (± SD)                             4.1 (±14)
     Type II/type III mixed cryoglobulins              2/1
     Mean C3 (± SD) in mg/dl (normal 60-130)           91 (±35)
     Mean C4 (± SD) in mg/dl (normal 20-55)            10 (±14)
     Antinuclear antibodies                            31%
     Antimitochondrial antibodies                      9%
     Anti-smooth muscle antibodies                     15%
     Anti-extractable nuclear antigen antibodies       9%
     Anti-HCV RNA                                      92%
     Anti-HBV antibodies                               30%
     HBsAg                                             1%

*Evaluated at the end of the patient followup period.

     There are different presenting clinical-serological patterns that vary from mild arthralgia
and sporadic purpura in those with MC alone, to more severe cutaneous and systemic
involvement of classical MCs [1-4]. In all such patients, the disease combines MC with RF
activity, low C4 levels, and the clinical-pathological features of orthostatic purpura due to
leukocytoclastic vasculitis (LCV) with variable multiorgan involvement. Patients chronically
infected with HCV demonstrate asymptomatic serum MC that precedes the clinical onset of
disease by years to decades [1, 4].

     Conversely, some patients show typical cryoglobulinemic manifestations without serum
cryoglobulins. The absence of this serological hallmark is not surprising since cryoglobulins
represent only a portion of IC that cryoprecipitate, which may be transient and vary both
among patients and during follow-up in individual patients [1, 4]. Most experts agree that
repeated cryoglobulin determinations are necessary for a definite diagnosis in such patients.
Cutaneous manifestations are the commonest in CV, with orthostatic purpura, the
pathognomonic feature, varying largely in dimension and diffusion to sporadic isolated

            Complimentary Contributor Copy
   252   253   254   255   256   257   258   259   260   261   262